实践指南:颈性与眼性前庭诱发肌源性电位检测
推荐:cVEMP阈值和校正波幅、oVEMP波幅和阈值可用于区分上半规管裂综合征(SCDS)与对照(Level C阳性);证据不足以确定其识别球囊/椭圆囊相关前庭功能或诊断前庭神经炎/梅尼埃病(Level U);未证实对良性阵发性位置性眩晕或前庭性偏头痛有用(Level C阴性)。
要点
- cVEMP阈值和校正波幅可区分SCDS与对照(Level C)。
- oVEMP波幅和阈值可区分SCDS与正常对照(Level C)。
- cVEMP/oVEMP对前庭神经炎、梅尼埃病等诊断价值证据不足(Level U)。
核心结论
- cVEMP和oVEMP可用于辅助区分上半规管裂综合征(SCDS)与对照,但对其他前庭疾病诊断价值证据不足或阴性。
主要发现
- cVEMP阈值区分SCDS与对照:2项III类研究,敏感度86%-91%,特异度90%-96%。
- cVEMP校正波幅区分SCDS与对照:2项III类研究,敏感度100%,特异度93%。
- oVEMP波幅区分SCDS与正常对照:3项III类研究,敏感度77%-100%,特异度98%-100%。
- oVEMP阈值辅助区分SCDS与对照:3项III类研究,敏感度70%-100%,特异度77%-100%。
关键数值与推荐
- Level C阳性:临床医生可使用cVEMP刺激阈值区分SCDS与对照(2项III类研究)。
- Level C阳性:临床医生可使用校正cVEMP波幅区分SCDS与对照(2项III类研究)。
- Level C阳性:临床医生可使用oVEMP波幅区分SCDS与正常对照(3项III类研究)。
- Level C阳性:oVEMP阈值可辅助区分SCDS与对照(3项III类研究)。
- Level U:证据不足以确定cVEMP和oVEMP能否准确识别球囊/椭圆囊相关前庭功能,或诊断前庭神经炎/梅尼埃病。
临床怎么用
- 临床可应用cVEMP阈值、校正波幅及oVEMP波幅、阈值辅助区分SCDS与对照。
- 不推荐仅凭cVEMP/oVEMP诊断前庭神经炎、梅尼埃病、良性阵发性位置性眩晕或前庭性偏头痛。
局限性
- 纳入研究多为III类证据,证据等级有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To systematically review the evidence and make recommendations with regard to diagnostic utility of cervical and ocular vestibular evoked myogenic potentials (cVEMP and oVEMP, respectively). Four questions were asked: Does cVEMP accurately identify superior canal dehiscence syndrome (SCDS)? Does oVEMP accurately identify SCDS? For suspected vestibular symptoms, does cVEMP/oVEMP accurately identify vestibular dysfunction related to the saccule/utricle? For vestibular symptoms, does cVEMP/oVEMP accurately and substantively aid diagnosis of any specific vestibular disorder besides SCDS? METHODS: The guideline panel identified and classified relevant published studies (January 1980-December 2016) according to the 2004 American Academy of Neurology process. RESULTS AND RECOMMENDATIONS: Level C positive: Clinicians may use cVEMP stimulus threshold values to distinguish SCDS from controls (2 Class III studies) (sensitivity 86%-91%, specificity 90%-96%). Corrected cVEMP amplitude may be used to distinguish SCDS from controls (2 Class III studies) (sensitivity 100%, specificity 93%). Clinicians may use oVEMP amplitude to distinguish SCDS from normal controls (3 Class III studies) (sensitivity 77%-100%, specificity 98%-100%). oVEMP threshold may be used to aid in distinguishing SCDS from controls (3 Class III studies) (sensitivity 70%-100%, specificity 77%-100%). Level U: Evidence is insufficient to determine whether cVEMP and oVEMP can accurately identify vestibular function specifically related to the saccule/utricle, or whether cVEMP or oVEMP is useful in diagnosing vestibular neuritis or Ménière disease. Level C negative: It has not been demonstrated that cVEMP substantively aids in diagnosing benign paroxysmal positional vertigo, or that cVEMP or oVEMP aids in diagnosing/managing vestibular migraine.
引用
- Fife TD, Colebatch JG, Kerber KA, et al. Practice guideline: Cervical and ocular vestibular evoked myogenic potential testing: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2017. PMID: 29093067. doi:10.1212/WNL.0000000000004690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。